Though recognized as prime drug targets, membrane proteins largely remain
Enter AB Vector http://www.abvector.com. The San Diego-based company has developed ProFold vectors for co-expression of molecular chaperones with the protein of interest. Molecular chaperones enable proper folding of proteins, preventing them from forming inclusion bodies and rendering them less toxic to cells. Peter Pingerelli, business development manager for AB Vector, says previous efforts to co-express target proteins with chaperones failed largely because they used separate vectors to encode the two genes ...